4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-039405
Director acquired 2,550 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ekman Lars · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-06-26 | Grant or award : show line 1 in the form | +2,550 | 12,300 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-06-26 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +4,250 | $76.58 | 2030-06-26 | 4,250 | 4,250 | D |
Loading xslF345X03/doc4.xml…